*3.1.1.3 Treatment of adult inclusion conjunctivitis*

Adult inclusion conjunctivitis, a self-limiting condition, is brought on by the inoculation of the eye with infected vaginal fluids. Without treatment, the infection might resolve spontaneously in 6–18 months but more frequently the disease progresses to complicated/uncomplicated chlamydia or impair reproductive health. Also, ocular complications such as conjunctival scarring, punctate keratitis, and iritis may take place. To prevent morbidity and related complications, treatment should be given to all patients. Topical antibiotics alone are not sufficient due to the possible concomitant urogenital infection; therefore, combined therapy with systemic antibiotics is necessary. Systemic oral antibiotic therapy options include azithromycin 1 g, single-dose; doxycycline 100mg, twice a day for 7 days; tetracycline 100mg, four times a day for 7–10 days; or erythromycin 500mg, four times a day for 7 days. Of note, the usage of tetracycline and doxycycline during pregnancy is contraindicated and should be avoided. Adjunctive topical treatment of adult inclusion conjunctivitis includes antibacterial drugs such as erythromycin, gentamicin, tetracycline, and fluoroquinolones [48].
